BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5118450)

  • 1. A chemotactic factor for mononuclear leukocytes.
    Snyderman R; Shin HS; Hausman MH
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):387-90. PubMed ID: 5118450
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoattractants of leukocytes, with special reference to lymphocytes.
    Ward PA; Offen CD; Montgomery JR
    Fed Proc; 1971; 30(6):1721-4. PubMed ID: 4942048
    [No Abstract]   [Full Text] [Related]  

  • 3. Humoral mediators of chemotaxis of mononuclear leukocytes.
    Hausman MS; Snyderman R; Mergenhagen SE
    J Infect Dis; 1972 Jun; 125(6):595-602. PubMed ID: 5037013
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement as a mediator of inflammation: formation of biologically-active products after interaction of serum complement with endotoxins and antigen-antibody complexes.
    Mergenhagen SE
    J Periodontol; 1970 Apr; 41(4):202-4. PubMed ID: 4191699
    [No Abstract]   [Full Text] [Related]  

  • 5. A fragment of the third component of human complement with anaphylatoxin activity.
    Budzko DB; Bokisch VA; Müller-Eberhard HJ
    Biochemistry; 1971 Mar; 10(7):1166-72. PubMed ID: 5553323
    [No Abstract]   [Full Text] [Related]  

  • 6. The characteristics, isolation and synthesis of the phagocytosis stimulating peptide tuftsin.
    Nishioka K; Constantopoulos A; Satoh PS; Najjar VA
    Biochem Biophys Res Commun; 1972 Apr; 47(1):172-9. PubMed ID: 4112769
    [No Abstract]   [Full Text] [Related]  

  • 7. Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes.
    Shin HS; Gewurz H; Snyderman R
    Proc Soc Exp Biol Med; 1969 May; 131(1):203-7. PubMed ID: 5770101
    [No Abstract]   [Full Text] [Related]  

  • 8. The third component of the guinea pig complement system. I. Purification and characterization.
    Shin HS; Mayer MM
    Biochemistry; 1968 Aug; 7(8):2991-6. PubMed ID: 5666765
    [No Abstract]   [Full Text] [Related]  

  • 9. Derivatives of the complement component MuB1 (C5mu) and separation of a factor involved in the conversion of MuB1 to MuB1f.
    Naylor DH; Cinader B
    Int Arch Allergy Appl Immunol; 1970; 39(5-6):540-65. PubMed ID: 4250087
    [No Abstract]   [Full Text] [Related]  

  • 10. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
    WARD PA; COCHRANE CG; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):327-46. PubMed ID: 14316948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The generation of chemotactic activity for human leukocytes by the action of plasmin on human fibrinogen.
    McKenzie R; Pepper DS; Kay AB
    Thromb Res; 1975 Jan; 6(1):1-8. PubMed ID: 123093
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation of the sixth component of complement from human serum.
    Arroyave CM; Müller-Eberhard HJ
    Immunochemistry; 1971 Nov; 8(11):995-1006. PubMed ID: 4110102
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphokine production by C3b-stimulated B cells.
    Sandberg AL; Wahl SM; Mergenhagen SE
    J Immunol; 1975 Jul; 115(1):139-44. PubMed ID: 1080163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properdin factor D. II. Activation to D by properdin.
    Fearon DT; Austen KF; Ruddy S
    J Exp Med; 1974 Aug; 140(2):426-36. PubMed ID: 4211020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological properties of esteroprotease isolated from the submaxillary gland of mice.
    Angeletti M; Sbaraglia G; De Campora E; Frati L
    Life Sci II; 1973 Apr; 12(7):297-305. PubMed ID: 4700527
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro studies of a chemotactic lymphokine in the guinea pig.
    Wahl SM; Altman LC; Oppenheim JJ; Mergenhagen SE
    Int Arch Allergy Appl Immunol; 1974; 46(5):768-84. PubMed ID: 4601881
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a).
    Kay AB; Shin HS; Austen KF
    Immunology; 1973 Jun; 24(6):969-76. PubMed ID: 4123965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of guinea pig lymphocyte-derived chemotactic factor for fibroblasts.
    Postlethwaite AE; Kang AH
    J Immunol; 1980 Mar; 124(3):1462-6. PubMed ID: 7358987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural elements of anaphylatoxin obtained by contact activation of hog serum.
    Liefländer M; Dielenberg D; Schmidt G; Vogi W
    Hoppe Seylers Z Physiol Chem; 1972 Mar; 353(3):385-92. PubMed ID: 5028204
    [No Abstract]   [Full Text] [Related]  

  • 20. Protease inhibitors in guinea pig serum. I. Isolation of two functionally different trypsin inhibitors from guinea pig serum.
    Kobayashi S; Nagasawa S
    Biochim Biophys Acta; 1974 Apr; 342(2):372-81. PubMed ID: 4545525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.